Navigation Links
YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
Date:11/18/2010

l molecule therapeutic with dual mechanisms of vascular disruption and cytotoxicity, and is currently in a Phase II trial for glioblastoma multiforme. In addition to YM's three clinical stage products, the Company has a library of more than 4,000 novel compounds identified through internal research conducted at YM BioSciences Australia which are currently being evaluated.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that nimotuzumab will continue to demonstrate a competitive safety profile in ongoing and future clinical trials; that our JAK1/JAK2 inhibitor CYT387 and our VDA small molecule CYT997 will generate positive efficacy and safety data in future clinical trials; that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Ardea Biosciences to Present at Two Upcoming Investor Conferences
2. YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
3. YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL OF ITS JAK1/JAK2 INHIBITOR, CYT387, IN MYELOFIBROSIS
4. Regado Biosciences Awarded Three Grants from the Federal Government to Advance Research of Lead Programs
5. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
6. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
7. X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells
8. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
9. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
10. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500â„¢
11. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Michigan (PRWEB) , ... September 03, 2015 , ... ... to release its non-invasive hydration monitoring wearable early 2016. , The device, ... level using proprietary optical and electrical sensing technology. These sensors track trending ...
(Date:9/2/2015)... Sept. 2, 2015 Research and ... addition of Jain PharmaBiotech,s new report ... their offering. An increasing ... biotechnology industries is anticipated. Nanotechnology will be ... - from formulations for optimal delivery to ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Biochips and ... their offering. This report is an ... applications. The report starts with a description of ... Technologies include array comparative genomic hybridization (CGH), copy ...
(Date:9/2/2015)... Research and Markets ( ... new report "Gene Therapy - Technologies, Markets and ... for gene therapy are difficult to estimate as there ... is marketed in China since ... 2014-2024. The estimates are based on epidemiology of diseases ...
Breaking Biology Technology:Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2
... ... revolutionary Trusted LASIK Surgeons directory service and website at www.TrustedLASIKSurgeons.com ... find a highly qualified LASIK surgeon who can help improve their chances ... is a unique screening process ensuring that only those who are among ...
... of Standards and Technology (NIST) has issued a new ruler, ... it sets some records. Designed to be the most accurate ... measuring toola calibration standard for X-ray diffractionboasts uncertainties below a ... the size of a neutron. The new ruler is ...
... ... Association (DIA), in collaboration with FDA and PhRMA, will host Modeling and Simulation in ... , ... -- The Drug Information Association (DIA) , in collaboration with FDA and PhRMA, ...
Cached Biology Technology:LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 2LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 3LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 4LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 5LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 6LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 7New NIST nano-ruler sets some very small marks 2DIA/FDA/PhRMA Conference To Expand The Role Of Modeling And Simulation In Clinical Drug Development 2DIA/FDA/PhRMA Conference To Expand The Role Of Modeling And Simulation In Clinical Drug Development 3
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... key concern for enterprises, banks, government organizations, telecommunications, ... and numeric keypads were previously being used to ... introduction of two-factor authentication, wherein individuals could gain ... two different components, such as hardware devices and ...
(Date:8/28/2015)... According to a new market ... Type (Pen & Paper Based, Hosted, Biometrics), Service, Application ... Research), Vertical and Region - Global Forecast to 2020", ... grow from USD 2.4 Billion in 2015 to USD ... Rate (CAGR) of 25.6% from 2015 to 2020. ...
(Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
Breaking Biology News(10 mins):Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... State University will battle for the BCS National College ... if the game was held in the Louisiana wetlands ... wetlands are being lost at the rate of approximately ... this rapid destruction, the two universities joined forces in ...
... Identity Theft Red Flag, Legislation January 1, 2008 with ... Tenn., Jan. 2 With only ten months to ... Accurate Transactions Act),also known as the "Red Flag Rules," ... written plan for detecting and,responding to transaction patterns and ...
... State University have found that the number of copies of ... in a mouse model. Publishing in the Jan. 3 issue ... Down syndrome in humans, can repress tumor growth. We ... people with Down syndrome develop cancer less often than other ...
Cached Biology News:LSU and Ohio State battle on football field, collaborate in research field 2NXG Strategies Launches Nation's First Website Dedicated to Red Flag Compliance 2Gene dose affects tumor growth 2
DNA Purification...
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
Recombinant Viral CCI/Fc Chimera, CF...
... • Guinea Pig serum is collected from ... N-02: Citrate N-04: Heparin ... Potassium Oxalate N-10: EDTA (Na) ... N-07: CPD N-09: K3EDTA ...
Biology Products: